CME CME GROUP INC revenue, earnings and financials

For the quarter ended September 30, 2026, CME GROUP INC reported revenue of $1.74B (up 13.0% from a year earlier), net income of $1.04B and diluted EPS of $2.89; over the last four quarters revenue was $6.97B and net income $4.42B; for the fiscal year ended December 2025 revenue was $6.52B, up 6.4% on the year before.

CME annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $6.52B, gross profit n/a, operating income $4.23B, net income $4.07B (margin 62.5%), EPS $11.16
• Fiscal year ended Dec 2024: revenue $6.13B, gross profit n/a, operating income $3.93B, net income $3.53B (margin 57.5%), EPS $9.67
• Fiscal year ended Dec 2023: revenue $5.58B, gross profit n/a, operating income $3.44B, net income $3.23B (margin 57.8%), EPS $8.86
• Fiscal year ended Dec 2022: revenue $5.02B, gross profit n/a, operating income $3.02B, net income $2.69B (margin 53.6%), EPS $7.40
• Fiscal year ended Dec 2021: revenue $4.69B, gross profit n/a, operating income $2.65B, net income $2.64B (margin 56.2%), EPS $7.29

CME quarterly revenue and earnings

• Quarter ended Sep 30, 2026: revenue $1.74B (up 13.0% year over year), net income $1.04B, EPS $2.89
• Quarter ended Jun 30, 2026: revenue $1.71B (up 0.8% year over year), net income $1.04B, EPS $2.88
• Quarter ended Mar 31, 2026: revenue $1.88B (up 14.5% year over year), net income $1.15B, EPS $3.18
• Quarter ended Dec 31, 2025 (from the annual report): revenue $1.65B (up 8.1% year over year), net income $1.18B, EPS $3.24
• Quarter ended Sep 30, 2025: revenue $1.54B (down 3.0% year over year), net income $908M, EPS $2.49
• Quarter ended Jun 30, 2025: revenue $1.69B (up 10.4% year over year), net income $1.03B, EPS $2.81
• Quarter ended Mar 31, 2025: revenue $1.64B (up 10.4% year over year), net income $956M, EPS $2.62
• Quarter ended Dec 31, 2024 (from the annual report): revenue $1.53B (up 6.0% year over year), net income $875M, EPS $2.40
• Quarter ended Sep 30, 2024: revenue $1.58B (up 18.4% year over year), net income $913M, EPS $2.50
• Quarter ended Jun 30, 2024: revenue $1.53B (up 12.7% year over year), net income $883M, EPS $2.42
• Quarter ended Mar 31, 2024: revenue $1.49B (up 3.2% year over year), net income $855M, EPS $2.35
• Quarter ended Dec 31, 2023 (from the annual report): revenue $1.44B (up 19.2% year over year), net income $814M, EPS $2.23
• Quarter ended Sep 30, 2023: revenue $1.34B (up 9.0% year over year), net income $750M, EPS $2.06
• Quarter ended Jun 30, 2023: revenue $1.36B (up 9.9% year over year), net income $778M, EPS $2.14
• Quarter ended Mar 31, 2023: revenue $1.44B (up 7.1% year over year), net income $884M, EPS $2.43
• Quarter ended Dec 31, 2022 (from the annual report): revenue $1.21B (up 5.3% year over year), net income $638M, EPS $1.76
• Quarter ended Sep 30, 2022: revenue $1.23B (up 10.6% year over year), net income $680M, EPS $1.87
• Quarter ended Jun 30, 2022: revenue $1.24B (up 4.9% year over year), net income $663M, EPS $1.82
• Quarter ended Mar 31, 2022: revenue $1.35B (up 7.4% year over year), net income $711M, EPS $1.95
• Quarter ended Dec 31, 2021 (from the annual report): revenue $1.15B, net income $626M, EPS $1.69

CME cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $4.28B, share buybacks n/a, dividends $5.00 per share
• Fiscal year ended Dec 2024: operating cash flow $3.69B, share buybacks n/a, dividends $10.40 per share
• Fiscal year ended Dec 2023: operating cash flow $3.45B, share buybacks n/a, dividends $9.65 per share
• Fiscal year ended Dec 2022: operating cash flow $3.06B, share buybacks n/a, dividends $8.50 per share
• Fiscal year ended Dec 2021: operating cash flow $2.40B, share buybacks n/a, dividends $5.90 per share

CME balance sheet

• Sep 30, 2026: cash $2.20B, total assets $192B, total liabilities $166B, shareholders' equity $26.6B
• Jun 30, 2026: cash $2.14B, total assets $195B, total liabilities $168B, shareholders' equity $26.5B
• Mar 31, 2026: cash $2.39B, total assets $202B, total liabilities $175B, shareholders' equity $26.6B
• Dec 31, 2025: cash $4.42B, total assets $198B, total liabilities $170B, shareholders' equity $28.7B
• Sep 30, 2025: cash $2.45B, total assets $187B, total liabilities $159B, shareholders' equity $28.2B
• Jun 30, 2025: cash $1.98B, total assets $180B, total liabilities $152B, shareholders' equity $27.7B
• Mar 31, 2025: cash $1.41B, total assets $158B, total liabilities $131B, shareholders' equity $27.0B
• Dec 31, 2024: cash $2.89B, total assets $137B, total liabilities $111B, shareholders' equity $26.5B

What is CME's revenue?

CME GROUP INC reported $6.97B of revenue over its last four quarters, through September 30, 2026.

Is CME profitable?

Yes. CME GROUP INC earned $4.42B over the last four quarters.

What is CME's EPS?

Diluted earnings per share over the last four quarters were $12.19; $2.89 in the latest quarter.

Does CME pay a dividend?

CME GROUP INC paid $5.00 per share in dividends in the fiscal year ended December 2025.

CME ownership and insider trades · All stocks